This nanocomplex effectively upregulates UCP1 and COX5B expression by activating the transcription axis of PPARγ/PGC1α and HSF1/PGC1α, thereby promoting white adipose tissue browning and improving obesity (Scheme 1A). The gene discussed is COX5B; the disease is obesity disorder.